QR-010 + Placebo
Phase 1/2Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Cystic Fibrosis
Conditions
Cystic Fibrosis
Trial Timeline
Jun 1, 2015 → Sep 14, 2017
NCT ID
NCT02532764About QR-010 + Placebo
QR-010 + Placebo is a phase 1/2 stage product being developed by ProQR for Cystic Fibrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02532764. Target conditions include Cystic Fibrosis.
Hype Score Breakdown
Clinical
13
Activity
8
Company
2
Novelty
4
Community
3
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02532764 | Phase 1/2 | Completed |
Competing Products
20 competing products in Cystic Fibrosis